SunBridge C18 5 µm, featuring exceptional alkaline durability enabled by Ultra Hybrid Technology, was launched in February 2025. Subsequently, SunBridge C18 3 µm was launched in April 2025. SunBridge C18 3 µm is effective for improving separation performance and ensuring stable operation in oligonucleotide analysis under high-temperature and high-pH conditions.
Fig. Part of Application No. 1209: Oligonucleotide (2) using SunBridge C18 3 µm [PDF]
